Notably, the classifier exhibits a lower detection rate for early-stage (I-II) than advanced stage ESCC (III-IV), which might be related to the higher methylation levels of HOXL10 and HOXD1 on advanced samples. This evidence concerns the gene HOXD1 and esophageal squamous cell carcinoma.